USD 5.58
(-2.26%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.68 Million USD | 32.33% |
2022 | 2.02 Million USD | 74.91% |
2021 | 1.16 Million USD | 20.33% |
2020 | 964 Thousand USD | 159.84% |
2019 | 371 Thousand USD | -37.01% |
2018 | 589 Thousand USD | -43.15% |
2017 | 1.03 Million USD | 25.58% |
2016 | 825 Thousand USD | -16.83% |
2015 | 992 Thousand USD | -28.89% |
2014 | 1.39 Million USD | -6.19% |
2013 | 1.48 Million USD | 14.21% |
2012 | 1.3 Million USD | -70.99% |
2011 | 4.48 Million USD | 59.32% |
2010 | 2.81 Million USD | -3.36% |
2009 | 2.91 Million USD | -2.05% |
2008 | 2.97 Million USD | 82.02% |
2007 | 1.63 Million USD | 68.56% |
2006 | 970 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 2.1 Million USD | -5.78% |
2024 Q1 | 2.44 Million USD | -9.09% |
2024 Q2 | 2.23 Million USD | -8.56% |
2023 FY | 2.68 Million USD | 32.33% |
2023 Q1 | 1.99 Million USD | -1.63% |
2023 Q4 | 2.68 Million USD | 16.49% |
2023 Q3 | 2.3 Million USD | 12.33% |
2023 Q2 | 2.05 Million USD | 2.81% |
2022 Q2 | 1.71 Million USD | 10.13% |
2022 Q1 | 1.56 Million USD | 34.48% |
2022 Q4 | 2.02 Million USD | 25.02% |
2022 Q3 | 1.62 Million USD | -5.53% |
2022 FY | 2.02 Million USD | 74.91% |
2021 Q4 | 1.16 Million USD | 7.01% |
2021 FY | 1.16 Million USD | 20.33% |
2021 Q3 | 1.08 Million USD | 0.56% |
2021 Q2 | 1.07 Million USD | 4.76% |
2021 Q1 | 1.02 Million USD | 6.74% |
2020 Q4 | 964 Thousand USD | 30.8% |
2020 FY | 964 Thousand USD | 159.84% |
2020 Q1 | 701 Thousand USD | 88.95% |
2020 Q2 | 686 Thousand USD | -2.14% |
2020 Q3 | 737 Thousand USD | 7.43% |
2019 Q2 | 720 Thousand USD | 13.74% |
2019 FY | 371 Thousand USD | -37.01% |
2019 Q4 | 371 Thousand USD | -6.55% |
2019 Q3 | 397 Thousand USD | -44.86% |
2019 Q1 | 633 Thousand USD | 7.47% |
2018 Q2 | 1.03 Million USD | -14.52% |
2018 FY | 589 Thousand USD | -43.15% |
2018 Q3 | 830 Thousand USD | -19.88% |
2018 Q4 | 589 Thousand USD | -29.04% |
2018 Q1 | 1.21 Million USD | 16.99% |
2017 Q2 | 806 Thousand USD | -28.29% |
2017 Q3 | 849 Thousand USD | 5.33% |
2017 Q1 | 1.12 Million USD | 36.24% |
2017 Q4 | 1.03 Million USD | 22.03% |
2017 FY | 1.03 Million USD | 25.58% |
2016 Q2 | 1.15 Million USD | 13.12% |
2016 FY | 825 Thousand USD | -16.83% |
2016 Q1 | 1.02 Million USD | 2.92% |
2016 Q4 | 825 Thousand USD | -23.33% |
2016 Q3 | 1.07 Million USD | -6.84% |
2015 Q3 | 678 Thousand USD | -29.96% |
2015 Q4 | 992 Thousand USD | 46.31% |
2015 Q2 | 968 Thousand USD | -2.42% |
2015 FY | 992 Thousand USD | -28.89% |
2015 Q1 | 992 Thousand USD | -28.89% |
2014 FY | 1.39 Million USD | -6.19% |
2014 Q4 | 1.39 Million USD | -28.2% |
2014 Q1 | 2.04 Million USD | 37.53% |
2014 Q2 | 1.96 Million USD | -4.01% |
2014 Q3 | 1.94 Million USD | -1.02% |
2013 Q2 | 1.33 Million USD | -21.04% |
2013 Q4 | 1.48 Million USD | -29.22% |
2013 FY | 1.48 Million USD | 14.21% |
2013 Q1 | 1.68 Million USD | 29.57% |
2013 Q3 | 2.1 Million USD | 57.73% |
2012 Q3 | 2.76 Million USD | -34.3% |
2012 Q2 | 4.2 Million USD | -12.73% |
2012 Q1 | 4.81 Million USD | 7.26% |
2012 FY | 1.3 Million USD | -70.99% |
2012 Q4 | 1.3 Million USD | -52.83% |
2011 Q1 | 3.22 Million USD | 14.45% |
2011 Q4 | 4.48 Million USD | -14.35% |
2011 Q3 | 5.24 Million USD | 25.15% |
2011 Q2 | 4.18 Million USD | 29.87% |
2011 FY | 4.48 Million USD | 59.32% |
2010 Q1 | 2.91 Million USD | -0.1% |
2010 Q3 | 3.24 Million USD | 49.13% |
2010 Q4 | 2.81 Million USD | -13.19% |
2010 FY | 2.81 Million USD | -3.36% |
2010 Q2 | 2.17 Million USD | -25.27% |
2009 FY | 2.91 Million USD | -2.05% |
2009 Q4 | 2.91 Million USD | 17.21% |
2009 Q3 | 2.48 Million USD | 0.0% |
2008 FY | 2.97 Million USD | 82.02% |
2008 Q4 | 2.97 Million USD | 0.0% |
2008 Q1 | 2.51 Million USD | 0.0% |
2007 FY | 1.63 Million USD | 68.56% |
2006 FY | 970 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Xeris Biopharma Holdings, Inc. | 38.83 Million USD | 93.087% |
Arrowhead Pharmaceuticals, Inc. | - USD | -Infinity% |
Viridian Therapeutics, Inc. | - USD | -Infinity% |
Organovo Holdings, Inc. | 297 Thousand USD | -804.04% |